NVS

Novartis AG

D
NVS
USD
-0.51
(-0.4941%)
Market Closed
32,850.00
Volume
7.235
EPS
3.68
Div Yield
23.343
P/E
209,570,140,008.77
Market Cap
Today
-0.4941%
1 Week
2.488%
1 Month
10.216%
6 Months
9.185%
12 Months
5.565%
Year To Date
1.703%
All Time
0%
News

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
B
BIIB
-5.45
(-2.3148%)
USD
LLY
LLY
-15.73
(-1.9975%)
USD
MRK
MRK
-0.84
(-0.6376%)
USD
PFE
PFE
0.115
(0.3991%)
USD
GSK
GSK
-0.83
(-1.8158%)
USD
SNY
SNY
-0.18
(-0.3671%)
USD
AMGN
AMGN
-4.27
(-1.3383%)
USD
AZN
AZN
0.06
(0.0779%)
USD
BMY
BMY
-0.44
(-0.9874%)
USD
JNJ
JNJ
1.59
(1.0412%)
USD
L
LCI
-0.005
(-0.3021%)
USD

Title:
Novartis AG

Sector:
Healthcare
Industry:
Drug Manufacturers - General
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Do you need help or have a question?
Contact Us